Search
                    Autism Paid Clinical Trials in Indiana
A listing of 4  Autism  clinical trials  in Indiana  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 4 of 4
        
        
    
                The state of Indiana currently has 4 active clinical trials seeking participants for Autism research studies. These trials are conducted in various cities, including Indianapolis, South Bend, Fort Wayne and Evansville. 
            
                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    
                
                                    Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
                                
            
            
        Recruiting
                            
            
                This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism spectrum disorder.             
        
        
    Gender:
                ALL
            Ages:
                Between 5 years and 17 years
            Trial Updated:
                07/07/2025
            
            Locations: Clinical Site, Indianapolis, Indiana         
        
        
            Conditions: Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder
        
            
        
    
                
                                    Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
                                
            
            
        Recruiting
                            
            
                This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (ASD) based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Text Revision (DSM-5-TR) and confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version (K-SADS-PL).             
        
        
    Gender:
                ALL
            Ages:
                Between 5 years and 17 years
            Trial Updated:
                07/03/2025
            
            Locations: Clinical Site, Evansville, Indiana  +1 locations         
        
        
            Conditions: Irritability Associated With Autism Spectrum Disorder
        
            
        
    
                
                                    Use of Eye Tracking to Aid in Autism Risk Detection
                                
            
            
        Recruiting
                            
            
                The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.             
        
        
    Gender:
                ALL
            Ages:
                Between 12 months and 48 months
            Trial Updated:
                03/04/2025
            
            Locations: Riley Hospital for Children, Indianapolis, Indiana         
        
        
            Conditions: Autism
        
            
        
    
                
                                    COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
                                
            
            
        Recruiting
                            
            
                Purpose: The purpose of this project is to develop and test the COMPASS \[Collaborative Model for Competence and Success\] Across Settings (CAST) intervention to enhance the goal setting and attainment skills of autistic youth. Despite federal education law mandating transition services as part of the Individualized Education Program (IEP) for ensuring good outcomes for students with disabilities, current educational practices have been unable to demonstrate that autistic students experience pos...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 16 years and 99 years
            Trial Updated:
                03/06/2024
            
            Locations: Ball State University, Muncie, Indiana         
        
        
            
        
    